Zuluvape Receives PMTA Acceptance Letter From the US FDA
Zuluvape is pleased to announce that on October 28, 2020 we received our Premarket Tobacco Product Application (PMTA) Acceptance Letter from the U.S. Food and Drug Administration. We submitted our application to the FDA on September 5, 2020 seeking the FDA’s authorization for the marketing and sale of our e-liquid products. This letter confirms that Zuluvape’s application has met the statutory and regulatory requirements based upon Section 910 of the FD&C Act.
